Archives

Aripiprazole (Abilify) is a licensed treatment for moderate to severe manic episodes in young people aged 13+ with bipolar 1 disorder. Other antipsychotics,  such as quetiapine and risperidone, [...]

Pain is a commonly experienced symptom and this article looks at some points to consider when prescribing analgesics for patients with a mental health condition. There are four main groups of [...]

The use of “high doses” of anti-psychotics is associated with increased clinical risk to patients. Despite the Royal College of Psychiatrists providing guidance on High Dose Antipsychotic [...]

PGDs provide a legal framework that allows a medicine to be supplied or administered to a patient without a prescription. PGDs are not currently widely used in independent hospitals as medication [...]

July 2013 – Atomoxetine is indicated for ADHD in children over 6 years, but is now also licensed for the treatment of adults where symptoms persist. Note- It is currently the only medicine [...]

This clinical guideline provides advice on the care and management of children and young people with autism, which is reported to affect 1% of the population.  About 70% of people with autism [...]

NICE has produced a clinical guideline on the prevention, detection and management of acute kidney injury, formally known as acute renal failure or kidney failure. It emphasises that early [...]

Codeine has been associated with several child fatalities, largely due to its conversion to morphine in the liver.  This can cause excessive morphine blood levels in patients who metabolise more [...]

Metoclopramide (Maxolon®) used to treat nausea and vomiting. The MHRA recommends that indications for use should be restricted due to the risk of neurological side-effects,  particularly in [...]

We have recently launched the latest addition to our Portfolio of Training, our new Mental Health Act clinical training seminar. It covers the specific legal requirements for treating inpatients [...]